First-of-its-kind instrument officially ushers in new era of X-ray science

“This marks the beginning of a new era of science with compact accelerator-based X‑ray sources,” said Robert Kaindl, who directs ASU’s Compact X-ray Free Electron Laser (CXFEL) Labs at the Biodesign Institute and is a professor in the Department of Physics. “The CXLS provides hard X-ray pulses with high flux, stability and ultrashort durations, in a very compact footprint. This way, matter can be resolved at its fundamental scales in space and time, enabling new discoveries across many fields — from next-generation materials for computing and information science, to renewable energy, biomolecular dynamics, drug discovery and human health.”Continue reading

RESI Boston June 2023

Life Science Nation is hosting a RESI conference which will be hybrid, June 5-7th. It will take place onsite on Monday June 5th at the Westin Copley Place from 8am – 5pm Eastern Time, and digitally on the 6th and 7th on the Partnering Platform. LSN is offering Arizona Bioindustry Association (AZBio) members a discounted registration for their early-stage startupsContinue reading

FAST Program Applications

FEDERAL & STATE TECHNOLOGY PARTNERSHIP PROGRAM

The Small Business Administration’s Federal and State Technology (FAST) Partnership Program is designed to support programs that advance innovative, technology-driven small businesses. The Arizona Commerce Authority has partnered with the Small Business Administration (SBA) to facilitate the FAST program in Arizona.Continue reading

Exact Sciences and PGA Tour Champions Extend Partnership Through 2027

Tucson, Ariz. (February 1, 2023) – The PGA TOUR Champions, the Tucson Conquistadores, the First Tee Tucson, and Exact Sciences, the maker of Cologuard®, announced today that the Madison, Wisconsin-based company will now be the presenting sponsor of the Cologuard Classic. The announcement also extends Cologuard’s title sponsorship through the 2027 season. The 2023 Cologuard Classic by Exact Sciences will take place at the Omni Tucson National Resort from February 27th through March 5th and will have a $2.2 million purse, with $330,000 to the winner.Continue reading

Aqualung Therapeutics Concludes ALT-100 Antibody (mAb) Dosing in Its P1a Study with no Reported SAE’s. Will Engage FDA for Clearance of the P2a PUERTA Study in Moderate/Severe Acute Respiratory Distress Syndrome (ARDS) Patients

TUCSON, AZ / ACESSWIRE / January 31, 2023 / Aqualung Therapeutics, an early stage immunotherapeutics company with a novel anti-inflammatory and anti-fibrotic therapeutic platform for life-threatening unchecked inflammation/fibrosis, today announced that it has engaged Novotech, a leading Asia Pacific centered, full-service contract research organization (“CRO”) in the Asia-Pacific, United States and Europe, for its upcoming Phase 2a PUERTA clinical trial utilizing the humanized ALT-100 mAb. Aqualung currently plans to initiate its Phase 2a clinical trial in Australia starting in Q2 2023. The study will enroll moderate/severe ARDS subjects in hospital locations in Australia as well at multiple sites in the United States.Continue reading

AZAdvances Talent Program Internship Opportunities

A component of the  AZAdvances Talent Program, AZAdvances internships are designed to support Arizona students as they explore career paths in health and life sciences.  Internships are created in partnership with AZBio member organizations and are supported though grants and donations to the Opportunity Through Entrepreneurship Foundation’s benefiting the AZAdvances initiative.Continue reading